{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:11:55Z","timestamp":1786990315426,"version":"build-2736575974"},"reference-count":110,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.humpath.2004.02.007","type":"journal-article","created":{"date-parts":[[2004,6,7]],"date-time":"2004-06-07T07:55:43Z","timestamp":1086594943000},"page":"649-662","source":"Crossref","is-referenced-by-count":231,"title":["Prognostic parameters of endometrial carcinoma"],"prefix":"10.1016","volume":"35","author":[{"given":"Jaime","family":"Prat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2004.02.007_BIB1","first-page":"825","article-title":"Surgical staging in endometrial cancer","volume":"63","author":"Boronow","year":"1984","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB2","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/0002-9378(85)90371-0","article-title":"Risk factors and recurrent patterns in stage I endometrial cancer","volume":"151","author":"DiSaia","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB3","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8","article-title":"Surgical pathological spread patterns of endometrial cancer. A Gynecologic Oncology Group study","volume":"60","author":"Creasman","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2004.02.007_BIB4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0090-8258(91)90086-K","article-title":"Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium. A Gynecologic Oncology Group study","volume":"40","author":"Morrow","year":"1991","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB5","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/0002-9378(90)90399-R","article-title":"Evaluation of unfavorable histological subtypes in endometrial adenocarcinoma","volume":"162","author":"Wilson","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/1097-0142(19950101)75:1<81::AID-CNCR2820750114>3.0.CO;2-F","article-title":"The utility of the revised International Federation of Gynecology and Obstetrics histological grading of endometrial adenocarcinoma using a defined nuclear grading system. A Gynecologic Oncology Group study","volume":"75","author":"Zaino","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2004.02.007_BIB7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","article-title":"Two pathogenetic types of endometrial carcinoma","volume":"15","author":"Bokhman","year":"1983","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB8","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/0046-8177(95)90203-1","article-title":"Endometrial intraepithelial carcinoma","volume":"26","author":"Ambros","year":"1995","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB9","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/00000478-200006000-00004","article-title":"Minimal uterine serous carcinoma","volume":"24","author":"Wheeler","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB10","first-page":"228","article-title":"A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analysis","volume":"81","author":"Lax","year":"1997","journal-title":"Verh Dtsch Ges Path"},{"key":"10.1016\/j.humpath.2004.02.007_BIB11","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1053\/hupa.2001.25929","article-title":"Molecular pathology of endometrial hyperplasia and carcinoma","volume":"32","author":"Matias-Guiu","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB12","first-page":"1671","article-title":"Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma","volume":"148","author":"Caduff","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB13","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S0046-8177(98)90430-0","article-title":"Microsatellite instability in endometrial carcinomas","volume":"29","author":"Catas\u00fas","year":"1998","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB14","first-page":"4736","article-title":"PTEN\/MMAC1 mutations in endometrial cancers","volume":"57","author":"Risinger","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2004.02.007_BIB15","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0046-8177(00)80244-0","article-title":"PTEN mutations in endometrial carcinomas. A molecular and clinicopathological analysis of 38 cases","volume":"31","author":"Bussaglia","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB16","first-page":"177","article-title":"p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis","volume":"150","author":"Tashiro","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB17","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0046-8177(97)90084-8","article-title":"Loss of heterozygosity in usual and special variant carcinomas of the endometrium","volume":"28","author":"Tritz","year":"1997","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB18","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0090-8258(92)90130-B","article-title":"Uterine papillary serous carcinoma","volume":"47","author":"Carcangiu","year":"1992","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB19","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/1097-0142(19911115)68:10<2293::AID-CNCR2820681032>3.0.CO;2-V","article-title":"The significance of squamous differentiation in endometrial carcinoma","volume":"68","author":"Zaino","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2004.02.007_BIB20","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/1097-0142(19920115)69:2<488::AID-CNCR2820690236>3.0.CO;2-O","article-title":"Endometrial adenocarcinoma with squamous differentiation","volume":"69","author":"Abeler","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2004.02.007_BIB21","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/1097-0142(19820415)49:8<1511::AID-CNCR2820490802>3.0.CO;2-6","article-title":"Carcinoma of the endometrium: I. A clinicopathological study of clear cell carcinoma and secretory carcinoma","volume":"49","author":"Christopherson","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2004.02.007_BIB22","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00004347-198512000-00005","article-title":"Secretory adenocarcinoma of the endometrium","volume":"4","author":"Tobon","year":"1985","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004347-198301000-00001","article-title":"Ciliated carcinoma, a variant of endometrial adenocarcinoma","volume":"2","author":"Hendrickson","year":"1983","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00004347-198512000-00001","article-title":"Endometrial papillary adenocarcinomas","volume":"4","author":"Chen","year":"1985","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB25","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1097\/00000478-199811000-00008","article-title":"Villoglandular adenocarcinoma of the endometrium: A clinicopathological study of 61 cases. A Gynecologic Oncology Group study","volume":"22","author":"Zaino","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB26","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/00000478-198312000-00001","article-title":"Primary mucinous adenocarcinoma of the endometrium","volume":"7","author":"Ross","year":"1983","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00000478-198203000-00002","article-title":"Uterine papillary serous carcinoma","volume":"6","author":"Hendrickson","year":"1982","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB28","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0090-8258(90)90250-O","article-title":"Serous papillary carcinoma of the endometrium","volume":"39","author":"Abeler","year":"1990","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB29","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/(SICI)1097-0142(19961015)78:8<1740::AID-CNCR14>3.0.CO;2-Y","article-title":"Clear cell carcinoma of the endometrium","volume":"78","author":"Abeler","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2004.02.007_BIB30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1006\/gyno.1998.5147","article-title":"Papillary serous and clear cell carcinoma limited to endometrial curettings in FIGO stage 1a and 1b endometrial adenocarcinoma","volume":"71","author":"Aquino-Parsons","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB31","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/modpathol.3880053","article-title":"Problems in the differential diagnosis of endometrial hyperplasia and carcinoma","volume":"13","author":"Silverberg","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1525-1438.1992.02010009.x","article-title":"Carcinoma of the endometrium in Norway","volume":"2","author":"Abeler","year":"1992","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.humpath.2004.02.007_BIB33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0090-8258(89)90027-9","article-title":"Announcements. FIGO stages: 1998 revision","volume":"35","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1006\/gyno.1999.5422","article-title":"An analysis of two versus three grades for endometrial carcinoma","volume":"74","author":"Taylor","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB35","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/00000478-200009000-00002","article-title":"A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advanced-stage tumors with favorable and unfavorable prognosis","volume":"24","author":"Lax","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB36","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/(SICI)1097-0142(19960315)77:6<1115::AID-CNCR17>3.0.CO;2-4","article-title":"Pathological models to predict outcome for women with endometrial adenocarcinoma: The importance of the distinction between surgical stage and clinical stage. A Gynecologic Oncology Group study","volume":"77","author":"Zaino","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2004.02.007_BIB37","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1002\/1097-0142(19910615)67:12<3093::AID-CNCR2820671226>3.0.CO;2-L","article-title":"Endometrial adenocarcinoma in Norway. A study of a total population","volume":"67","author":"Abeler","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2004.02.007_BIB38","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/1097-0142(19920101)69:1<200::AID-CNCR2820690132>3.0.CO;2-D","article-title":"The new International Federation of Gynecology and Obstetrics surgical staging and survival rates in early endometrial carcinoma","volume":"69","author":"Gal","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2004.02.007_BIB39","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0090-8258(92)90276-O","article-title":"The prognostic significance of surgical staging for carcinoma of the endometrium","volume":"45","author":"Wolfson","year":"1992","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB40","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ssu.2980100107","article-title":"FIGO stage, histology, histological grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system","volume":"10","author":"Kosary","year":"1994","journal-title":"Sem Surg Oncol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB41","first-page":"142","article-title":"Surgical pathological staging of endometrial adenocarcinoma and results of treatment","volume":"45","author":"Maneschi","year":"1992","journal-title":"Eur J Gynecol Oncol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB42","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1002\/1097-0142(19820615)49:12<2547::AID-CNCR2820491224>3.0.CO;2-0","article-title":"Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma","volume":"49","author":"Kurman","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2004.02.007_BIB43","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00000478-199504000-00001","article-title":"Proposed criteria for the diagnosis of well-differentiated endometrial carcinoma. A diagnostic test for myoinvasion","volume":"19","author":"Longacre","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB44","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/1097-0142(19830915)52:6<1026::AID-CNCR2820520617>3.0.CO;2-3","article-title":"Adenocarcinoma of the endometrium. Analysis of 262 cases with disease limited to the uterine corpus: Treatment comparisons","volume":"52","author":"Eifel","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2004.02.007_BIB45","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0090-8258(92)90296-U","article-title":"Identification of patients with stage I uterine endometrioid adenocarcinoma at high risk of recurrence by DNA ploidy, myometrial invasion, and vascular invasion","volume":"45","author":"Ambros","year":"1992","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB46","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1006\/gyno.1994.1158","article-title":"Traditional and nontraditional histopathological predictors of recurrence in uterine endometrioid adenocarcinoma","volume":"54","author":"Lee","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB47","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0090-8258(84)90057-X","article-title":"The prognostic significance of adenomyosis in endometrial carcinoma","volume":"17","author":"Hall","year":"1984","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB48","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0090-8258(90)90376-V","article-title":"Endometrial adenocarcinoma with variable-level myometrial involvement limited to adenomyosis","volume":"37","author":"Jacques","year":"1990","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB49","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/gyno.1993.1107","article-title":"Endometrial adenocarcinoma involving adenomyosis without true myometrial invasion is characterized by frequent preceding estrogen therapy, low histological grades, and excellent prognosis","volume":"49","author":"Mittal","year":"1993","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB50","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00004347-200207000-00006","article-title":"Adenocarcinoma arising from uterine adenomyosis","volume":"21","author":"Koshiyama","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB51","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00000478-199901000-00007","article-title":"Diffusely infiltrative endometrial adenocarcinoma","volume":"23","author":"Longacre","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB52","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1097\/00000478-198810000-00003","article-title":"Diffusely infiltrating adenocarcinoma of the endometrium","volume":"12","author":"Mittal","year":"1988","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB53","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/01.pgp.0000092161.33490.a9","article-title":"Unusual epithelial and stromal changes in myoinvasive endometrioid adenocarcinoma","volume":"22","author":"Murray","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB54","first-page":"120","article-title":"Serous carcinoma in endometrial polyps","volume":"3","author":"Silva","year":"1990","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB55","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0090-8258(90)90306-6","article-title":"Intraoperative frozen section diagnosis of depth of myometrial invasion in endometrial adenocarcinoma","volume":"37","author":"Fanning","year":"1990","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB56","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0090-8258(90)90009-A","article-title":"Assessment of depth of myometrial invasion in endometrial adenocarcinoma","volume":"38","author":"Goff","year":"1990","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB57","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1002\/1097-0142(19850415)55:8<1753::AID-CNCR2820550823>3.0.CO;2-P","article-title":"The prognostic significance of lymph-vascular space invasion in stage I endometrial cancer","volume":"55","author":"Hanson","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2004.02.007_BIB58","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/j.1471-0528.1987.tb02275.x","article-title":"The prognostic significance of lymphatic vascular space invasion in endometrial adenocarcinoma","volume":"94","author":"Sivridis","year":"1987","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB59","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0090-8258(91)90334-2","article-title":"Lymphovascular space involvement","volume":"42","author":"Gal","year":"1991","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB60","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00004347-198506000-00005","article-title":"Endometrial carcinoma","volume":"4","author":"Beckner","year":"1985","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB61","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00004347-199310000-00003","article-title":"Association of endometrial epithelial metaplasias with endometrial carcinoma and hyperplasia in Japanese and American women","volume":"12","author":"Katu","year":"1993","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB62","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0090-8258(91)90084-I","article-title":"Prognostic significance of the extent of cervical involvement by endometrial cancer","volume":"40","author":"Fanning","year":"1991","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB63","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/gyno.1999.5454","article-title":"Survival of women with surgical stage II endometrial cancer","volume":"74","author":"Eltabbakh","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB64","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1525-1438.2002.01076.x","article-title":"Clinicopathological study of the pattern and significance of cervical involvement in cases of endometrial adenocarcinoma","volume":"12","author":"Jordan","year":"2002","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.humpath.2004.02.007_BIB65","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/gyno.1997.4732","article-title":"Surgical staging of endometrial cancer: Evolution, evaluation, and responsible challenge. A personal perspective","volume":"66","author":"Boronow","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB66","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1097\/00000478-200308000-00005","article-title":"Endometrial endometrioid adenocarcinoma with a deceptive pattern of spread to the uterine cervix","volume":"27","author":"Tambouret","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB67","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00004347-200201000-00002","article-title":"Distinction between endometrial and endocervical adenocarcinoma","volume":"21","author":"Castrillon","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB68","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00004347-200201000-00003","article-title":"A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas","volume":"21","author":"McCluggage","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB69","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0090-8258(92)90246-F","article-title":"Positive peritoneal cytology is an adverse risk factor in endometrial carcinoma only if there is other evidence of extrauterine disease","volume":"46","author":"Kadar","year":"1992","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB70","first-page":"775","article-title":"The prognostic significance of peritoneal cytology for stage I endometrial cancer","volume":"74","author":"Turner","year":"1989","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB71","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0090-8258(90)90116-3","article-title":"Prognostic value of peritoneal cytology in endometrial carcinoma","volume":"36","author":"Grimshaw","year":"1990","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB72","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/1097-0142(19861001)58:7<1518::AID-CNCR2820580723>3.0.CO;2-X","article-title":"Endometrial adenocarcinoma. A multiparameter clinicopathological analysis including the DNA profile and the sex steroid hormone receptors","volume":"58","author":"Geisinger","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2004.02.007_BIB73","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/1097-0142(19890401)63:7<1378::AID-CNCR2820630724>3.0.CO;2-Q","article-title":"Prognostic value of quantitative pathological features and DNA content in individual patients with stage I endometrial adenocarcinoma","volume":"63","author":"Van Der Putten","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2004.02.007_BIB74","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0090-8258(90)90005-6","article-title":"DNA ploidy, morphometry, and nuclear grade as prognostic factors in endometrial carcinoma","volume":"38","author":"Sorbe","year":"1990","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB75","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00004347-199107000-00006","article-title":"Prognostic significance of proliferation in endometrial adenocarcinomas","volume":"10","author":"Stendahl","year":"1991","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB76","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0090-8258(89)90165-0","article-title":"Flow cytometric DNA analysis of stage I endometrioid carcinoma","volume":"34","author":"Britton","year":"1989","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB77","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0029-7844(95)00037-R","article-title":"HER-2\/neu, p53, and DNA analyses as prognosticators for survival in endometrial carcinoma","volume":"85","author":"Pisani","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB78","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00004347-199607000-00002","article-title":"Carcinoma of the endometrium","volume":"15","author":"Nordstrom","year":"1996","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB79","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/1097-0142(19860401)57:7<1385::AID-CNCR2820570724>3.0.CO;2-V","article-title":"Progesterone receptors in two groups of endometrial carcinoma","volume":"57","author":"Deligdisch","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2004.02.007_BIB80","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/1097-0142(19861001)58:7<1506::AID-CNCR2820580722>3.0.CO;2-6","article-title":"Correlation of female sex steroid hormone receptors with histological and ultrastructural differentiation in adenocarcinoma of the endometrium","volume":"58","author":"Geisinger","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2004.02.007_BIB81","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/ajcp\/94.3.247","article-title":"Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part II: Correlation between biochemical and immunohistochemical methods and survival","volume":"94","author":"Carcangiu","year":"1990","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB82","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1006\/gyno.1993.1211","article-title":"Steroid receptor concentrations in endometrial carcinoma","volume":"50","author":"Kadar","year":"1993","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB83","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/01.PGP.0000070850.25718.A5","article-title":"Angiogenesis, p53, and bcl-2 expression as prognostic indicators in endometrial cancer","volume":"22","author":"Erdem","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB84","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00004347-199607000-00003","article-title":"Immunohistochemical analysis of endometrial adenocarcinoma for bcl-2 and p53 in relation to expression of sex steroid receptor and proliferative activity","volume":"15","author":"Yamauchi","year":"1996","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB85","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/(SICI)1097-0215(19980417)79:2<153::AID-IJC10>3.0.CO;2-B","article-title":"Bcl-2 expression and prognosis of patients with endometrial carcinoma","volume":"79","author":"Sakuragi","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2004.02.007_BIB86","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0002-9378(91)90615-X","article-title":"Overexpression of HER-2\/neu in endometrial cancer is associated with advanced-stage disease","volume":"164","author":"Berchuck","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB87","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/1097-0142(19940915)74:6<1778::AID-CNCR2820740621>3.0.CO;2-5","article-title":"Uterine papillary serous adenocarcinoma","volume":"74","author":"Prat","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2004.02.007_BIB88","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1006\/exmp.1999.2289","article-title":"Fluorescence in situ hybridization analysis of HER-2\/neu, c-myc, and p53 in endometrial cancer","volume":"67","author":"Williams","year":"1999","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/gyno.2000.5751","article-title":"Molecular and cytogenetic pretreatment risk assessment in endometrial carcinoma","volume":"77","author":"Silverman","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB90","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0046-8177(03)00124-2","article-title":"Immunohistochemical expression of cyclins, cyclin-dependent kinases, tumor-suppressor gene products, Ki-67, and sex steroid receptors in endometrial carcinoma","volume":"34","author":"Shih","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB91","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0046-8177(98)80002-6","article-title":"Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression","volume":"29","author":"Lax","year":"1998","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB92","first-page":"2779","article-title":"Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas","volume":"4","author":"Salvesen","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2004.02.007_BIB93","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1006\/gyno.1995.1202","article-title":"Prognostic value of DNA ploidy and S-phase fraction in stage I endometrial carcinoma","volume":"58","author":"Pfisterer","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB94","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/363558a0","article-title":"Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism of colonic carcinogenesis","volume":"363","author":"Ionov","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2004.02.007_BIB95","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/(SICI)1097-0215(19960220)69:1<38::AID-IJC9>3.0.CO;2-X","article-title":"Overview of natural history, pathology, molecular genetics and management of HNPCC (Lynch syndrome)","volume":"69","author":"Lynch","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2004.02.007_BIB96","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1038\/sj.onc.1202178","article-title":"MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas","volume":"17","author":"Esteller","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2004.02.007_BIB97","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0029-7844(00)01165-0","article-title":"Favorable survival associated with microsatellite instability in endometrioid endometrial cancers","volume":"97","author":"Maxwell","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB98","first-page":"4736","article-title":"PTEN\/MMAC1 mutations in endometrial cancers","volume":"57","author":"Risinger","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2004.02.007_BIB99","first-page":"3935","article-title":"Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies","volume":"57","author":"Tashiro","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2004.02.007_BIB100","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0092-8674(00)80674-1","article-title":"The multiple roles of PTEN in tumor suppression","volume":"100","author":"Di Cristofano","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2004.02.007_BIB101","first-page":"3005","article-title":"PTEN mutation in endometrial cancers is associated with favorable clinical and pathological characteristics","volume":"4","author":"Risinger","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2004.02.007_BIB102","first-page":"2636","article-title":"PTEN mutation located only outside exons 5, 6, and 7 is an independent predictor of favorable survival in endometrial carcinomas","volume":"7","author":"Minaguchi","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2004.02.007_BIB103","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/1097-0215(20010101)91:1<22::AID-IJC1002>3.0.CO;2-S","article-title":"PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma","volume":"91","author":"Salvesen","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2004.02.007_BIB104","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1677\/erc.0.0100203","article-title":"Loss of PTEN expression followed by Akt phosphorylation is a poor prognostic factor for patients with endometrial cancer","volume":"10","author":"Terakawa","year":"2003","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.humpath.2004.02.007_BIB105","first-page":"3526","article-title":"Beta-catenin mutations in carcinoma of the uterine endometrium","volume":"58","author":"Fukuchi","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2004.02.007_BIB106","doi-asserted-by":"crossref","first-page":"7981","DOI":"10.1038\/sj.onc.1205924","article-title":"Abnormalities of the APC\/beta-catenin pathway in endometrial cancer","volume":"21","author":"Moreno-Bueno","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2004.02.007_BIB107","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1053\/hupa.2002.30723","article-title":"CTNNB1 mutations and beta-catenin expression in endometrial carcinomas","volume":"33","author":"Mach\u0131\u0301n","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2004.02.007_BIB108","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1054\/bjoc.2000.1581","article-title":"Beta-catenin mutations and aberrant nuclear expression during endometrial tumorigenesis","volume":"84","author":"Saegusa","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2004.02.007_BIB109","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s004280000371","article-title":"Beta- and gamma-catenin expression in endometrial carcinoma. Relationship with clinicopathological features and microsatellite instability","volume":"438","author":"Palacios","year":"2001","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2004.02.007_BIB110","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH769>3.0.CO;2-9","article-title":"K-ras mutations in endometrial carcinomas with microsatellite instability","volume":"193","author":"Lagarda","year":"2001","journal-title":"J Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817704001352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817704001352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T06:56:39Z","timestamp":1549522599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817704001352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":110,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S0046817704001352"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2004.02.007","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}